The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route

[1]  Lee-Jah Chang,et al.  Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial , 2019, Human vaccines & immunotherapeutics.

[2]  R. Kennedy,et al.  Immunosenescence and human vaccine immune responses , 2019, Immunity & Ageing.

[3]  T. Mueller,et al.  Age-associated decrease in de novo donor-specific antibodies in renal transplant recipients reflects changing humoral immunity , 2019, Immunity & Ageing.

[4]  D. Baarle,et al.  Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis , 2019, Medical Microbiology and Immunology.

[5]  C. Weyand,et al.  Regulation of miR-181a expression in T cell aging , 2018, Nature Communications.

[6]  T. Ottenhoff,et al.  Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults , 2018, Front. Immunol..

[7]  David K. Kim,et al.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018 , 2018, MMWR. Morbidity and mortality weekly report.

[8]  R. Janssen,et al.  Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. , 2018, Vaccine.

[9]  Noele P. Nelson,et al.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[10]  David K. Kim,et al.  Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2018* , 2017, Annals of Internal Medicine.

[11]  W. Shi,et al.  The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes , 2016, The Journal of Immunology.

[12]  P. Klenerman,et al.  T cell responses to cytomegalovirus , 2016, Nature Reviews Immunology.

[13]  R. Koup,et al.  Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques. , 2015, Journal of immunological methods.

[14]  Shixia Wang,et al.  Effect of vaccine administration modality on immunogenicity and efficacy , 2015, Expert review of vaccines.

[15]  G. Poland,et al.  The weight of obesity on the human immune response to vaccination. , 2015, Vaccine.

[16]  J. Soucie,et al.  Hepatitis B vaccination is effective by subcutaneous route in children with bleeding disorders: a universal data collection database analysis , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  B. Malissen,et al.  The origins and functions of dendritic cells and macrophages in the skin , 2014, Nature Reviews Immunology.

[18]  Fangjia Lu,et al.  Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant. , 2013, Vaccine.

[19]  A. Díaz,et al.  A comparative review of aging and B cell function in mice and humans. , 2013, Current opinion in immunology.

[20]  C. Weyand,et al.  Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.

[21]  A. Klip,et al.  Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. , 2013, American journal of physiology. Endocrinology and metabolism.

[22]  E. Krishnan,et al.  Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity , 2012, Nature Medicine.

[23]  W. Li,et al.  Ageing‐Associated Changes in Cellular Immunity Based on the SENIEUR Protocol , 2012, Scandinavian journal of immunology.

[24]  R. Ozdemir,et al.  Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: a prospective randomized study. , 2012, Vaccine.

[25]  A. Moorman,et al.  Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. , 2012, Vaccine.

[26]  M. Jadoul,et al.  Meta-Analysis: The Impact of Nutritional Status on the Immune Response to Hepatitis B Virus Vaccine in Chronic Kidney Disease , 2012, Digestive Diseases and Sciences.

[27]  S. Hamza,et al.  Immune response of 23‐valent pneumococcal polysaccharide vaccinated elderly and its relation to frailty indices, nutritional status, and serum zinc levels , 2012, Geriatrics & gerontology international.

[28]  B. Grubeck‐Loebenstein,et al.  Gain and Loss of T Cell Subsets in Old Age—Age-Related Reshaping of the T Cell Repertoire , 2011, Journal of Clinical Immunology.

[29]  C. Tung,et al.  Effect of Needle Length When Immunizing Obese Adolescents With Hepatitis B Vaccine , 2010, Pediatrics.

[30]  T. Ross,et al.  Impaired immune responses in the lungs of aged mice following influenza infection , 2009, Respiratory Research.

[31]  Beatrix Grubeck-Loebenstein,et al.  Vaccination in the elderly: an immunological perspective. , 2009, Trends in immunology.

[32]  L. Rink,et al.  The immune system and the impact of zinc during aging , 2009, Immunity & Ageing.

[33]  S. Nakajima,et al.  Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels , 2009, Immunity & Ageing.

[34]  G. Pawelec,et al.  From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly , 2009, Biogerontology.

[35]  O. Burghuber,et al.  BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study , 2009, Respiratory research.

[36]  D. Weiskopf,et al.  Biology of immune responses to vaccines in elderly persons. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  I. Cook.  Evidence based route of administration of vaccines , 2008, Human vaccines.

[38]  L. Ziegler‐Heitbrock,et al.  The CD14+ CD16+ blood monocytes: their role in infection and inflammation , 2007, Journal of leukocyte biology.

[39]  B. Friedman,et al.  Psychometric Properties of the 15‐Item Geriatric Depression Scale in Functionally Impaired, Cognitively Intact, Community‐Dwelling Elderly Primary Care Patients , 2005, Journal of the American Geriatrics Society.

[40]  M. Roggendorf,et al.  Immunogenicity of combined hepatitis A and B vaccine in elderly persons. , 2003, Vaccine.

[41]  K. Leder,et al.  The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  J. Charboneau,et al.  Determination of deltoid fat pad thickness. Implications for needle length in adult immunization. , 1997, JAMA.

[43]  J. Blumberg,et al.  Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. , 1997, JAMA.

[44]  G. Schiffman,et al.  Impaired Antibody Responses to Pneumococcal Polysaccharide in Elderly Patients with Low Serum Vitamin B12 Levels , 1996, Annals of Internal Medicine.

[45]  R. Lorans,et al.  Injection granulomas. Intramuscle or intrafat? , 1994, Archives of family medicine.

[46]  M. Osterholm,et al.  Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. , 1993, JAMA.

[47]  S. Hadler,et al.  Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. , 1989, Vaccine.

[48]  G. Pravettoni,et al.  Immune response to hepatitis b vaccine given at different injection sites and by different routes a controlled randomized study , 1988, European Journal of Epidemiology.

[49]  S. Lemon,et al.  Immunogenicity of plasma-derived hepatitis B vaccine , 1986, Journal of General Internal Medicine.

[50]  H. Müller-Hermelink,et al.  Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.

[51]  W. P. Cockshott,et al.  Intramuscular or intralipomatous injections? , 1982, The New England journal of medicine.

[52]  G. Fillenbaum,et al.  The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. , 1981, Journal of gerontology.

[53]  D. Greenblatt,et al.  Intramuscular injection of drugs. , 1976, The New England journal of medicine.

[54]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[55]  D. Mollison,et al.  Uptake of IgG after intramuscular and subcutaneous injection. , 1972, Lancet.

[56]  C. Weyand,et al.  Understanding immune senescence to improve vaccine responses , 2014 .

[57]  C. Bridges,et al.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014 , 2014, Annals of internal medicine.

[58]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[59]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[60]  Richard W. Hamming,et al.  Introduction to Applied Numerical Analysis. , 1971 .